We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.8%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$796M
AUM Growth
-$185M
Cap. Flow
-$163M
Cap. Flow %
-20.42%
Top 10 Hldgs %
3.37%
Holding
1,987
New
622
Increased
338
Reduced
393
Closed
624

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$5.34M
2
MSFT icon
Microsoft
MSFT
+$5.22M
3
OPLN
Openlane
OPLN
+$4.6M
4
AAPL icon
Apple
AAPL
+$4.51M
5
HRI icon
Herc Holdings
HRI
+$4.09M

Sector Composition

Rank Sector Weight
1 Healthcare 16.45%
2 Industrials 15.7%
3 Technology 14.88%
4 Consumer Discretionary 11.13%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMTX icon
1026
Immatics
IMTX
$1.32B
$266K 0.03%
+19,817
New +$248K
SO icon
1027
Southern Company
SO
$107B
$266K 0.03%
3,875
-18,800
-83% -$1.2M
PGTI
1028
DELISTED
PGT, Inc.
PGTI
$266K 0.03%
11,809
-12,513
-51% -$267K
HARP
1029
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$266K 0.03%
3,527
+1,043
+42% +$71.2K
AEE icon
1030
Ameren
AEE
$30.1B
$264K 0.03%
+2,968
New +$252K
BKH icon
1031
Black Hills Corp
BKH
$5.69B
$264K 0.03%
+3,738
New +$248K
HR
1032
DELISTED
Healthcare Realty Trust Incorporated
HR
$264K 0.03%
+8,356
New +$268K
XEL icon
1033
Xcel Energy
XEL
$48.8B
$263K 0.03%
+3,889
New +$254K
SLB icon
1034
SLB Ltd
SLB
$75B
$262K 0.03%
+8,748
New +$276K
USX
1035
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$262K 0.03%
+44,583
New +$335K
DNLI icon
1036
Denali Therapeutics
DNLI
$3.97B
$260K 0.03%
5,834
-9,058
-61% -$429K
GNW icon
1037
Genworth Financial
GNW
$3.71B
$260K 0.03%
64,192
-370,786
-85% -$1.54M
OPI
1038
DELISTED
Office Properties Income Trust
OPI
$260K 0.03%
+10,453
New +$269K
ZDGE icon
1039
Zedge
ZDGE
$38.9M
$260K 0.03%
30,576
-19,774
-39% -$217K
ATEX icon
1040
Anterix
ATEX
$1.94B
$259K 0.03%
4,407
-874
-17% -$53.1K
BORR
1041
Borr Drilling
BORR
$1.19B
$259K 0.03%
125,882
ICAD
1042
DELISTED
iCAD Inc
ICAD
$259K 0.03%
+36,001
New +$321K
VBIV
1043
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$257K 0.03%
+3,667
New +$309K
WCC
1044
WESCO International
WCC
$17.7B
$256K 0.03%
+1,947
New +$249K
CIEN icon
1045
Ciena
CIEN
$58.4B
$255K 0.03%
+3,309
New +$204K
CME icon
1046
CME Group
CME
$94.8B
$255K 0.03%
+1,115
New +$245K
HAIN icon
1047
Hain Celestial
HAIN
$53.7M
$255K 0.03%
5,992
-76,442
-93% -$3.26M
JBGS
1048
JBG SMITH
JBGS
$708M
$255K 0.03%
8,887
-10,389
-54% -$304K
SIX
1049
DELISTED
Six Flags Entertainment Corp.
SIX
$255K 0.03%
+5,988
New +$249K
EBF icon
1050
Ennis
EBF
$564M
$254K 0.03%
+12,999
New +$251K

Similar funds

GSA Capital Partners's Q4 2021 Portfolio in Review

As of Q4 2021, GSA Capital Partners held 1,987 positions worth $796M, down 19% from $982M the previous quarter. Its ten largest holdings account for 3.4% of the portfolio.

GSA Capital Partners withdrew a net $163M in Q4 2021, closing 624 positions and reducing 393 holdings. Its most notable exit was Morgan Stanley, an estimated $5.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

Against the trend, GSA Capital Partners opened a new position in Genius Sports worth $2.45M.

  • GSA Capital Partners's largest Q4 2021 buy was Genius Sports: 322,717 shares worth $2.45M.
  • GSA Capital Partners added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2021, an estimated $2.43M increase.
  • GSA Capital Partners's biggest Q4 2021 reduction was Microsoft, cutting an estimated $5.22M.
  • GSA Capital Partners fully exited Morgan Stanley in Q4 2021, selling an estimated $5.34M.
  • GSA Capital Partners's ten largest holdings make up 3.4% of its $796M portfolio in Q4 2021.
  • GSA Capital Partners opened 622 new positions and closed 624 in Q4 2021.
  • GSA Capital Partners's portfolio value fell 19% quarter-over-quarter to $796M.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.